会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • CYCLOSPORIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    • 环磷酰胺衍生物,其制备和含有它们的药物组合物
    • WO1998028329A1
    • 1998-07-02
    • PCT/FR1997002405
    • 1997-12-23
    • RHONE-POULENC RORER S.A.BARRIERE, Jean-ClaudeBASHIARDES, GeorgesCARRY, Jean-ChristopheEVERS, MichelFILOCHE, BrunoLECONTE, Jean-PierreMIGNANI, Serge
    • RHONE-POULENC RORER S.A.
    • C07K07/64
    • C07K7/645A61K38/00
    • The invention concerns cyclosporin derivatives characterised in that they comply with general formula (I) in which Alk is C2-C6 alkylene linear or branched or C3-C6 cycloalkylene and R is: either COOH or alkyloxycarbonyl, or -NR1R2 for which R1 and R2 identical or different are H, or alkyl, C2-C4 alkylene, C3-C6 cycloalkyl, phenyl optionally substituted (by halogen, alkyloxy, alkyloxycarbonyl, amino, alkylamino or dialkylamino) or are benzyl or saturated or unsaturated heterocyclic compound radicals containing 5 or 6 chains and 1 to 3 heteroatoms, or for which R1 and R2 form with the nitrogen atom to which they are bound a heterocyclic compound containing 4 to 6 chains capable of containing another heteroatom selected among N, O and S and optionally substituted by an alkyl, phenyl or benzyl, or a radical of general formula (I') for which R1 and R2 are defined as above, R3 is H or alkyl and n is a whole number from 2 to 4. The alkyl portions or radicals defined above are linear or branched and contain 1 to 4 carbon atoms as well as their pharmaceutically acceptable salts when they exist. These novel products are particularly useful for treating and or preventing retroviral infections.
    • 本发明涉及环孢菌素衍生物,其特征在于它们符合通式(I),其中Alk是直链或支链或C3-C6亚环烷基的C2-C6亚烷基,R是:COOH或烷氧基羰基,或-NR1R2,其中R1和R2相同 或不同的是H或烷基,C 2 -C 4亚烷基,C 3 -C 6环烷基,任选被(卤素,烷氧基,烷氧基羰基,氨基,烷基氨基或二烷基氨基)取代的苯基)或是含有5或6个链的苄基或饱和或不饱和杂环化合物 或1至3个杂原子,或者R1和R2与它们所连接的氮原子形成杂环化合物,该杂环化合物含有能够含有选自N,O和S中的另外的杂原子并且任选被烷基取代的4至6个链,苯基 或苄基,或其中R 1和R 2如上定义的通式(I')的基团,R 3为H或烷基,n为2至4的整数。上述烷基部分或自由基为直链或支链 当它们存在时,它们含有1至4个碳原子以及它们的药学上可接受的盐。 这些新产品对于治疗和/或预防逆转录病毒感染特别有用。
    • 2. 发明申请
    • NOVEL USE FOR PYRROLE DERIVATIVES
    • 用于光子衍生物的新用途
    • WO1997000073A1
    • 1997-01-03
    • PCT/FR1996000887
    • 1996-06-12
    • RHONE-POULENC RORER S.A.BACQUE, EricBASHIARDES, GeorgesDEREU, NorbertNEMECEK, Conception
    • RHONE-POULENC RORER S.A.
    • A61K31/44
    • C07D471/04A61K31/4439C07D487/04C07D513/04
    • A novel therapeutical use of pyrrole derivatives of general formula (I), wherein Het is a ring fused with pyrrole to form a pyrrolothiazole, tetrahydro-5,6,7,8-indolizine, dihydro-pyrrolothiazine or dihydropyrrolizine ring, R1 is a carboxamide, cyano, carboxy, alkyloxycarbonyl, acyl or imidazolylcarbonyl radical, R2 is a hydrogen or halogen atom or an alkyl, alkenyl, trihalomethyl or cyano radical, R3 is a hydrogen or halogen atom or a hydroxy or alkyl radical, and Het' is a pyridyl, pyridyl N-oxide or thiazolyl radical, the alkyl or acyl radicals being straight or branched and having 1-4 carbon atoms, and the alkenyl radicals being straight or branched and having 2-4 carbon atoms, and salts thereof, if any, for preparing a drug for treating conditions in which TNF is involved.
    • 通式(I)的吡咯衍生物的新型治疗用途,其中Het是与吡咯稠合形成吡咯噻唑,四氢-5,6,7,8-中氮茚,二氢吡咯并噻嗪或二氢吡咯烷环的环,R 1是甲酰胺 ,氰基,羧基,烷氧基羰基,酰基或咪唑基羰基,R2是氢或卤素原子或烷基,烯基,三卤甲基或氰基,R3是氢或卤素原子或羟基或烷基,Het'是吡啶基 ,N-氧化吡啶基或噻唑基,所述烷基或酰基为直链或支链并具有1-4个碳原子,所述链烯基为直链或支链并具有2-4个碳原子,及其盐(如果有的话), 制备用于治疗涉及TNF的病症的药物。
    • 5. 发明申请
    • NOVEL CYCLOSPORIN DERIVATIVES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    • 新型环磷酰胺衍生物,其制备方法和含有它们的药物组合物
    • WO1998028330A1
    • 1998-07-02
    • PCT/FR1997002406
    • 1997-12-23
    • RHONE-POULENC RORER S.A.BARRIERE, Jean-ClaudeBASHIARDES, GeorgesCARRY, Jean-ChristopheEVERS, MichelFILOCHE, BrunoMIGNANI, Serge
    • RHONE-POULENC RORER S.A.
    • C07K07/64
    • C07K7/645A61K38/00
    • The invention concerns cyclosporin derivatives of general formula (I) in which Alk is C2-C6 alkylene linear or branched or C3-C6 cycloalkylene and R is: either OH, COOH or alkyloxycarbonyl, or -NR1R2 for which R1 and R2 identical or different are H, or alkyl, C2-C4 alkylene, C3-C6 cycloalkyl, phenyl optionally substituted (by halogen, alkyloxy, alkyloxycarbonyl, amino, alkylamino or dialkylamino), or are benzyl or saturated or unsaturate heterocyclic compound containing 5 or 6 chains and 1 to 3 heteroatoms, or for which R1 and R2 form with the nitrogen atom to which they are bound a heterocyclic compound containing 4 to 6 chains capable of containing another heteroatom selected among N, O or S and optionally substituted by an alkyl, phenyl or benzyl, or a radical of general formula (I') for which R1 and R2 are as defined above, R3 is H or alkyl and n is a whole number from 2 to 4. The alkyl portions or radicals defined above are linear or branched and contain 1 to 4 carbon atoms, as well as their pharmaceutically acceptable salts when they do exist. These novel products are particularly useful for treating and/or preventing retroviral infections.
    • 本发明涉及通式(I)的环孢菌素衍生物,其中Alk是C2-C6亚烷基直链或支链或C3-C6亚环烷基,R是:OH,COOH或烷氧基羰基,或-NR1R2,其中R1和R2相同或不同 H或烷基,C 2 -C 4亚烷基,C 3 -C 6环烷基,任选被(卤素,烷氧基,烷氧基羰基,氨基,烷基氨基或二烷基氨基)取代的苯基,或者是含有5或6个链的苄基或饱和或不饱和杂环化合物, 3个杂原子,或其中R1和R2与其结合的氮原子形成的杂环化合物,其含有能够含有选自N,O或S中的另外的杂原子且任选被烷基,苯基或苄基取代的4至6个链的杂环化合物, 或其中R 1和R 2如上所定义的通式(I')基团,R 3为H或烷基,n为2至4的整数。上述烷基部分或自由基为直链或支链并含有1 至4个碳原子 当它们确实存在时,作为其药学上可接受的盐。 这些新产品对于治疗和/或预防逆转录病毒感染特别有用。